Literature DB >> 11317132

[Prevalence of dyspepsia in liver cirrhosis: a clinical and epidemiological investigation].

M Grassi1, B Albiani, A De Matteis, M Fontana, M C Lucchetta, S Raffa.   

Abstract

BACKGROUND: To evaluate the prevalence and severity of dyspepsia in patients with liver cirrhosis.
METHODS: A questionnaire was distributed to 33 consecutive patients suffering from liver cirrhosis (22 males and 11 females, mean age 65.5 years; 24 with post-hepatitis liver cirrhosis and 9 with alcohol- based cirrhosis) to evaluate dyspeptic symptoms. Patients receiving prolonged treatment at home with anti-acid drugs immediately prior to hospitalisation were excluded from the study.
RESULTS: Twenty-eight patients complained of dyspeptic disorders. An organic cause of symptoms could not be identified in 8 patients (24.2%), whereas the following were identified as the causes of organic dyspepsia in the remaining 20 patients, in order of frequency: gastroesophageal reflux disease (55%), congestive gastropathy (40%), gastric or duodenal ulcer (30%) and gallbladder stones (35%). Lastly, a combination of at least two of these morbid conditions was found in 10 patients (50%). The severity of dyspeptic symptoms was similar in both organic and functional forms; symptoms tend to occur with moderate intensity, worsening in parallel with the aggravation of liver disease.
CONCLUSIONS: Dyspepsia is a very frequent phenomenon in cirrhotic patients; it is normally sustained by an organic cause. The predominance of functional forms in liver cirrhosis is practically the same as that reported in the general population.

Entities:  

Mesh:

Year:  2001        PMID: 11317132

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  6 in total

1.  Gastroesophageal Reflux-Is It Uncommon in Indian Patients With Decompensated Liver Cirrhosis?

Authors:  Uday Sanglodkar; Mayank Jain; M J Alexander; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

2.  Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Authors:  Jun Zhang; Pei-Lin Cui; Dong Lv; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function.

Authors:  Mitsuyoshi Kobayashi; Fumihiko Kinekawa; Kazuya Matsuda; Shintaro Fujihara; Noriko Nishiyama; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Hideki Kobara; Akihiro Deguchi; Hirohito Yoneyama; Hirohito Mori; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

4.  High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases.

Authors:  Bing Li; Bin Zhang; Jun Wei Ma; Peng Li; Lei Li; Yun Ming Song; Hui Guo Ding
Journal:  BMC Gastroenterol       Date:  2010-06-04       Impact factor: 3.067

5.  The prevalence of functional dyspepsia using Rome III questionnaire among chronic hepatitis C patients.

Authors:  Hala I Mohamed; Hamdy A Mokarib; Zienab M Saad; Wael M Abd El Ghany
Journal:  BMC Gastroenterol       Date:  2016-03-03       Impact factor: 3.067

6.  Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis.

Authors:  Jen-Kuei Peng; Nilay Hepgul; Irene J Higginson; Wei Gao
Journal:  Palliat Med       Date:  2018-10-22       Impact factor: 4.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.